Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000101

Chief Medical Officer gave up 248 shares (to pay taxes)

  • Chief Medical Officer acquired 833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gheuens Sarah Chief Medical Officer 2022-12-02 Option exercise +833 9,261 D: show line 1 in the form
Gheuens Sarah Chief Medical Officer 2022-12-06 Shares withheld for taxes −248 $28.83 $7,150 9,013 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gheuens Sarah Chief Medical Officer 2022-12-02 Option exercise · Restricted stock units −833 0 D: show line 3 in the form
Loading xslF345X03/wf-form4_167036124284100.xml…